PATENT CLAIM ANALYSIS

Application Number: 15758293
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "130100"]

Abstract:
The present invention relates to a method for identifying a subject, which has peripartum cardiomyopathy (PPCM) or which has a risk for developing PPCM, wherein the method comprises analyzing the amount and/or activity of plasminogen activator inhibitor-1 (PAI-1); and/or the genotype of the PAI-1 gene. The invention also relates to an inhibitor of PAI-1 for use in the treatment of PPCM. Also a method of treating PPCM in a subject in need of such a treatment, wherein said method comprises administering to said subject an effective amount of an inhibitor of PAI-1 is comprised in the present invention. Moreover, the present invention further relates to the use of a binding molecule for identifying a subject, which has PPCM or which has a risk for developing PPCM, wherein said binding molecule specifically binds to PAI-1.

Claim (Index 5):
Method of  claim 1 , wherein said amount of plasminogen activator inhibitor-1 is analyzed by ELISA.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 90.0
- Lexical Diversity: 2.56897
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11573711', '11965323', '11443920', '13980530', '15155222']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6968738595978989
- 35 USC 102 Novelty (BERT): 0.5155204917329685
- Combined Prediction Score: 0.6787385228114059
- Mean Citation Score: 225.51469
- Max Citation Score: 246.39766
- Similarity Product: 156.94230322180152

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test